- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Dual RNase activity of IRE1 as a target for anticancer therapies ; day:18 ; month:9 ; year:2023 ; pages:1-17
Journal of cell communication and signaling ; (18.9.2023), 1-17
- Creator
-
Bartoszewska, Sylwia
Sławski, Jakub
Collawn, James F.
Bartoszewski, Rafał
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12079-023-00784-5
- URN
-
urn:nbn:de:101:1-2023120615094684228431
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bartoszewska, Sylwia
- Sławski, Jakub
- Collawn, James F.
- Bartoszewski, Rafał
- SpringerLink (Online service)
Other Objects (12)
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
p27kip1: a target for tumor therapies?
Validation and characterization of monoclonal antibodies to target cancer stem cells and to develop new anti-cancer therapies
Funktion und Zusammensetzung der nukleären RNase P und RNase MRP in Pflanzen : Funktion und Zusammensetzung der nukleärenRNase P und RNase MRP in Pflanzen
Clinical development of targeted and immune based anti-cancer therapies
Targeted RNase : humane Antikörper-RNase-Fusionen zur Bekämpfung von CD30+-Lymphomen
Selektion und Charakterisierung von RNase-stabiler RNA : Substratbindung an RNase T1
Targeted RNase : humane Antikörper-RNase-Fusionen zur Bekämpfung von CD30+-Lymphomen
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
p27kip1: a target for tumor therapies?
Validation and characterization of monoclonal antibodies to target cancer stem cells and to develop new anti-cancer therapies
Funktion und Zusammensetzung der nukleären RNase P und RNase MRP in Pflanzen : Funktion und Zusammensetzung der nukleärenRNase P und RNase MRP in Pflanzen
Clinical development of targeted and immune based anti-cancer therapies
Targeted RNase : humane Antikörper-RNase-Fusionen zur Bekämpfung von CD30+-Lymphomen
Selektion und Charakterisierung von RNase-stabiler RNA : Substratbindung an RNase T1
Targeted RNase : humane Antikörper-RNase-Fusionen zur Bekämpfung von CD30+-Lymphomen
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
p27kip1: a target for tumor therapies?
Validation and characterization of monoclonal antibodies to target cancer stem cells and to develop new anti-cancer therapies
Funktion und Zusammensetzung der nukleären RNase P und RNase MRP in Pflanzen : Funktion und Zusammensetzung der nukleärenRNase P und RNase MRP in Pflanzen
Clinical development of targeted and immune based anti-cancer therapies
Targeted RNase : humane Antikörper-RNase-Fusionen zur Bekämpfung von CD30+-Lymphomen
Selektion und Charakterisierung von RNase-stabiler RNA : Substratbindung an RNase T1